107 related articles for article (PubMed ID: 17851106)
1. Subjective cognitive dysfunction associated with drug-induced parkinsonism in schizophrenia.
Kim JH; Kim SY; Byun HJ
Parkinsonism Relat Disord; 2008; 14(3):239-42. PubMed ID: 17851106
[TBL] [Abstract][Full Text] [Related]
2. Non-motor cognitive-perceptual dysfunction associated with drug-induced parkinsonism.
Kim JH; Byun HJ
Hum Psychopharmacol; 2009 Mar; 24(2):129-33. PubMed ID: 19204914
[TBL] [Abstract][Full Text] [Related]
3. Association of subjective cognitive dysfunction with akathisia in patients receiving stable doses of risperidone or haloperidol.
Kim JH; Byun HJ
J Clin Pharm Ther; 2007 Oct; 32(5):461-7. PubMed ID: 17875112
[TBL] [Abstract][Full Text] [Related]
4. Cognitive dysfunction in drug induced parkinsonism (DIP).
Kim YD; Kim JS; Chung SW; Song IU; Yang DW; Hong YJ; Kim YI; Ahn KJ; Kim HT; Lee KS
Arch Gerontol Geriatr; 2011; 53(2):e222-6. PubMed ID: 21163539
[TBL] [Abstract][Full Text] [Related]
5. Subjective cognitive dysfunction in first-episode and chronic schizophrenic patients.
Moritz S; Lambert M; Andresen B; Böthern A; Naber D; Krausz M
Compr Psychiatry; 2001; 42(3):213-6. PubMed ID: 11349240
[TBL] [Abstract][Full Text] [Related]
6. Systematic evaluation of rating scales for drug-induced parkinsonism and recommendations for future research.
Knol W; Keijsers CJ; Jansen PA; van Marum RJ
J Clin Psychopharmacol; 2010 Feb; 30(1):57-63. PubMed ID: 20075649
[TBL] [Abstract][Full Text] [Related]
7. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
[TBL] [Abstract][Full Text] [Related]
8. Subjective emotional experience and cognitive impairment in drug-induced akathisia.
Kim JH; Lee BC; Park HJ; Ahn YM; Kang UG; Kim YS
Compr Psychiatry; 2002; 43(6):456-62. PubMed ID: 12439833
[TBL] [Abstract][Full Text] [Related]
9. Impairment of motor dexterity in schizophrenia assessed by a novel finger movement test.
Midorikawa A; Hashimoto R; Noguchi H; Saitoh O; Kunugi H; Nakamura K
Psychiatry Res; 2008 Jun; 159(3):281-9. PubMed ID: 18448171
[TBL] [Abstract][Full Text] [Related]
10. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
11. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
12. Validity and reliability of the Simpson-Angus Scale (SAS) in drug induced parkinsonism in the elderly.
Knol W; Keijsers CJ; Jansen PA; Belitser SV; Schobben AF; Egberts AC; van Marum RJ
Int J Geriatr Psychiatry; 2009 Feb; 24(2):183-9. PubMed ID: 18615779
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic-induced acute and chronic akathisia: a clinical comparison.
Kim JH; Jin YH; Kang UG; Ahn YM; Ha KS; Kim YS
Mov Disord; 2005 Dec; 20(12):1667-70. PubMed ID: 16078203
[TBL] [Abstract][Full Text] [Related]
14. Clinical and neuropsychological correlates of insight in schizophrenia and bipolar I disorder: does diagnosis matter?
Varga M; Magnusson A; Flekkøy K; David AS; Opjordsmoen S
Compr Psychiatry; 2007; 48(6):583-91. PubMed ID: 17954145
[TBL] [Abstract][Full Text] [Related]
15. The differential diagnoses of parkinsonism: findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics.
Munhoz RP; Werneck LC; Teive HA
Clin Neurol Neurosurg; 2010 Jun; 112(5):431-5. PubMed ID: 20347518
[TBL] [Abstract][Full Text] [Related]
16. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
Chino B; Nemoto T; Fujii C; Mizuno M
Psychiatry Clin Neurosci; 2009 Aug; 63(4):521-8. PubMed ID: 19531107
[TBL] [Abstract][Full Text] [Related]
17. Quantitative measurement of handwriting in the assessment of drug-induced parkinsonism.
Caligiuri MP; Teulings HL; Filoteo JV; Song D; Lohr JB
Hum Mov Sci; 2006 Oct; 25(4-5):510-22. PubMed ID: 16647772
[TBL] [Abstract][Full Text] [Related]
18. Dimensional structure of the Frankfurt Complaint Questionnaire in a sample of French students.
Yon V; Loas G; Monestes JL
Psychopathology; 2008; 41(2):85-9. PubMed ID: 18033977
[TBL] [Abstract][Full Text] [Related]
19. Schizotypal traits impact upon executive working memory and aspects of IQ.
Matheson S; Langdon R
Psychiatry Res; 2008 May; 159(1-2):207-14. PubMed ID: 18423612
[TBL] [Abstract][Full Text] [Related]
20. Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol.
Gallhofer B; Jaanson P; Mittoux A; Tanghøj P; Lis S; Krieger S
Pharmacopsychiatry; 2007 Nov; 40(6):275-86. PubMed ID: 18030652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
